Vanguard MSCI Index International Shares ETF

VGS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

Global X Battery Tech & Lithium ETF

ACDC

ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).

Actinogen Medical Limited

ACW

Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-16. The firm is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The firm is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamem’s mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. The company has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The firm conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamem’s therapeutic potential.

Ardiden Ltd

ADV

Ardiden Ltd. is a mineral exploration company, which engages in the exploration and evaluation of mineral resources. The company is headquartered in Perth, Western Australia. The company went IPO on 2005-10-25. The firm is focused on the gold exploration of its 100% owned Pickle Lake Gold Project in the Uchi Geological Sub province of north-west Ontario, Canada. The Pickle Lake Gold Project consists of approximately 1,088 square kilometers (km2) of prospective and connected landholdings with three existing gold deposits (Kasagiminnis, Dorothy and Dobie) and 23 other identified brownfields and Greenfields gold prospects. The four advanced Gold Deposits located within the Pickle Lake Gold Project include Kasagiminnis Gold Deposit, Dorothy and Dobie Deposit, New Patricia Gold Prospect, South Limb Gold Prospect, and Other Gold Prospects. The Kasagiminnis Deposit is located 40 kilometers (km) south-east of the Dorothy Deposit but forms part of the same regional mineralized system. The New Patricia Gold Prospect extends over 30 km of prospective geological setting directly along strike from the Golden Patricia Gold Mine.

Global X Robo Global Robotics & Automation ETF

ROBO

ROBO.AX was created on 2017-09-13 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the ROBO.AX Global Robotics and Automation Index (the Index)